MARKET

IDXGD

IDXGD

Interpace Biosciences Inc
OTCID
7.65
-22.35
-74.50%
Closed 15:50 08/28 EDT
OPEN
5.85
PREV CLOSE
30.00
HIGH
9.00
LOW
5.85
VOLUME
715
TURNOVER
5.17K
52 WEEK HIGH
11.90
52 WEEK LOW
0.770
MARKET CAP
42.38M
P/E (TTM)
8.67
1D
5D
1M
3M
1Y
5Y
1D
Interpace Biosciences announces 1-for-5 reverse split for Nasdaq uplisting
TipRanks · 2d ago
*Interpace Biosciences: Reverse Stk Split Will Become Effective at 12:01 AM ET on Aug 27 >IDXG
Dow Jones · 2d ago
*Interpace Biosciences Announces Reverse Stk Split to Support Proposed Nasdaq Uplisting
Dow Jones · 2d ago
Interpace Biosciences Announces Reverse Stock Split to Support Proposed Nasdaq Uplisting
Barchart · 3d ago
Weekly Report: what happened at IDXG last week (0817-0821)?
Weekly Report · 5d ago
Interpace Diagnostics Shareholders Approve Governance and Equity Plans
TipRanks · 08/21 10:29
Weekly Report: what happened at IDXG last week (0810-0814)?
Weekly Report · 08/17 10:09
Interpace Biosciences GAAP EPS of $0.01, revenue of $9.1M
Seeking Alpha · 08/10 21:02
More
About IDXGD
Interpace Biosciences, Inc. provides esoteric molecular diagnostic testing and pathology services to aid physicians in the evaluation of cancer risk. The Company’s clinical services business commercializes clinically useful molecular diagnostic tests and molecular pathology services. The Company develops and commercializes genomic tests and related first-line assays that can personalize medicine to help improve patient diagnosis and management. It has five commercialized molecular diagnostic tests: PancraGEN, PanDNA, ThyGeNEXT, ThyraMIR v2, and RespriDX. PancraGEN is a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians’ better risk-stratify pancreaticobiliary cancers using the Company’s proprietary PathFinderTG platform. PanDNA is an alternate reporting option of the PathFinderTG platform, which provides physicians the molecular only information. ThyGeNEXT is an oncogenic mutation panel that helps rule-in and rule-out malignancy in thyroid nodules.

Webull offers Interpace Biosciences Inc stock information, including OTCID: IDXGD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IDXGD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IDXGD stock methods without spending real money on the virtual paper trading platform.